Evidence map›Paper›PMID 41329040›Full record

ArticleBriefings in bioinformatics2025

Using a consensus machine learning approach to identify host biomarkers associated with treatment response in pulmonary tuberculosis.

Ruiqi Zhang, Fusheng Yao, Wenqi Liu, Qiao Lin, Yuanyuan Huang, Min Huang, Junyan He, Guobao Li, Guoliang Zhang

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruiqi ZhangNational Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen 518112, China.
Fusheng YaoKey Laboratory of Animal Biotechnology of the Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine Northwest A&F University, Yangling, 712100 Shanxi, China.
Wenqi LiuNational Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen 518112, China.
Qiao LinThe Baoan People's Hospital of Shenzhen, The Second Affiliated Hospital of Shenzhen University, Shenzhen, 518101  China.
Yuanyuan HuangNational Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen 518112, China.
Min HuangNational Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen 518112, China.
Junyan HeNational Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen 518112, China.
Guobao LiNational Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen 518112, China.
Guoliang ZhangNational Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen 518112, China.ORCID 0000-0002-3617-5449

Funding

Guangdong Science Fund for Distinguished Young Scholars 0620220214Major Project of Guangzhou National Laboratory GZNL2024A01009National Key Research and Development Plan 2021YFA1300902National Natural Science Foundation of China 82170009Sanming Project of Medicine in Shenzhen SZZYSM202311009Shenzhen High-level Hospital Construction FundShenzhen Medical Research Fund B2402040Shenzhen Scientific and Technological Foundation KCXFZ20211020163545004Shenzhen Scientific and Technological Foundation RCJC20221008092726022
6 · The paper itself

Abstract

The lack of reliable biomarkers to monitor treatment response constitutes a major challenge in tuberculosis (TB) management, often leading to under- or overtreatment with the standard six-month regimen. Here, we integrated amino acid and trace element profiles, along with four machine learning-based feature selection methods, to develop an evaluation model. Additionally, we investigated the dynamic expression patterns of genes associated with the identified features during TB treatment to gain functional insights. The consensus feature selection from the four methodologies identified 34 potential biomarkers. Notably, three trace elements-Antimony (Sb), Copper (Cu), and Strontium (Sr)-were consistently highlighted as significant biomarkers across all employed methods. Re-analysis of two public RNA-seq datasets revealed that genes associated with these three trace elements yielded higher Area Under Curve values in distinguishing cured TB from untreated TB. Subsequent gene expression profiling showed dynamic expression patterns for genes linked to these biomarkers, predominantly involving pathways of programmed cell death, signal transduction, and immune response. These findings suggest that the combination of Sb, Cu, and Sr may serve as a novel laboratory criterion for monitoring TB treatment response, providing a practical tool to guide clinical decisions and reduce adverse outcomes.

Indexed as

BiomarkersMachine LearningTuberculosis, PulmonaryGene Expression ProfilingHumansTreatment OutcomeBiomarkersbiomarkersmachine learningtreatment responsetuberculosis

Identifiers

PMID41329040
PMCPMC12670634

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.